Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vaxcyte (PCVX) Cash from Investing Activities (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Cash from Investing Activities data on record, last reported at -$233.4 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 289.28% to -$233.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $80.6 million, a 105.63% increase, with the full-year FY2025 number at $437.4 million, up 121.81% from a year prior.
  • Cash from Investing Activities reached -$233.4 million in Q1 2026 per PCVX's latest filing, down from $115.1 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for PCVX hit a ceiling of $123.3 million in Q1 2025 and a floor of -$917.0 million in Q3 2024.
  • A 5-year average of -$147.1 million and a median of -$13.9 million in 2023 define the central range for Cash from Investing Activities.
  • On a YoY basis, Cash from Investing Activities climbed as much as 287.91% in 2022 and fell as far as 43943.9% in 2022.
  • Tracing PCVX's Cash from Investing Activities over 5 years: stood at -$36.0 million in 2022, then surged by 61.27% to -$13.9 million in 2023, then plummeted by 3900.92% to -$557.2 million in 2024, then surged by 120.66% to $115.1 million in 2025, then crashed by 302.74% to -$233.4 million in 2026.
  • Business Quant data shows Cash from Investing Activities for PCVX at -$233.4 million in Q1 2026, $115.1 million in Q4 2025, and $121.2 million in Q3 2025.